International Journal of Cancer

Cover image for International Journal of Cancer

28 May 1992

Volume 51, Issue 3

Pages fmi–fmi, 339–508

  1. Masthead

    1. Top of page
    2. Masthead
    3. Special Report
    4. Human Cancer
    5. Experimental Cancer
    6. Announcements
    1. Masthead (page fmi)

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510301

  2. Special Report

    1. Top of page
    2. Masthead
    3. Special Report
    4. Human Cancer
    5. Experimental Cancer
    6. Announcements
  3. Human Cancer

    1. Top of page
    2. Masthead
    3. Special Report
    4. Human Cancer
    5. Experimental Cancer
    6. Announcements
    1. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis (pages 343–354)

      Roberto L. Ceriani, Curtis M. Chan, Frank S. Baratta, Luciano Ozzello, Carolyn M. Derosa and David V. Habif

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510303

    2. No influence of beta-carotene on smoking-induced dna damage as reflected by sister chromatid exchanges (pages 355–358)

      G. van Poppel, F. J. Kok, P. Duijzings and N. de Vogel

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510304

    3. Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times (pages 359–364)

      Ernst A. de Bruijn, Harm P. Sleeboom, Peter J. R. O. van Helsdingen, Allan T. van Oosterom, Ubbo R. Tjaden and Robert A. A. Maes

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510305

    4. A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme (pages 365–372)

      G. R. Howe, P. Ghadirian, H. B. Bueno de Mesquita, W. A. Zatonski, P. A. Baghurst, A. B. Miller, A. Simard, J. Baillargeon, F. de Waard, K. Przewozniak, A. J. McMichael, M. Jain, C. C. Hsieh, P. Maisonneuve, P. Boyle and A. M. Walker

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510306

    5. Loss of HLA class-I alleles, heavy chains and β2-microglobulin in colorectal cancer (pages 379–385)

      Loukas Kaklamanis, Kevin C. Gatter, Ann B. Hill, Neil Mortensen, Adrian L. Harris, Peter Krausa, Andrew McMichael, Julia G. Bodmer and Walter F. Bodmer

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510308

    6. High protein, saturated fat and cholesterol diet, and low levels of serum lipids in colorectal cancer (pages 386–389)

      A. Trichopoulou, A. Tzonou, C. C. Hsieh, N. Toupadaki, O. Manousos and D. Trichopoulos

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510309

    7. Risk of lung cancer among cigarette and pipe smokers in Southern China (pages 390–395)

      Jay H. Lubin, Li Jun-Yao, Xuan Xiang-Ghen, Cai Shu Kan, Luo Qing-Sheng, Yang Li Shen, Wang Jian-zhang, Yang Lan and William J. Blot

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510310

    8. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency (pages 396–403)

      P. K. Lipponen, M. J. Eskelinen, K. Jauhiainen, E. Harju, R. Terho and H. Haapasalo

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510311

    9. Expression and different polarity of aminopeptidase N in normal human colonic mucosa and colonic tumors (pages 404–411)

      Andrea Quaroni, Buford L. Nichols, Elaine Quaroni, Kelley Hurst, Lemuel Herrera, Milton M. Weiser and Stanley R. Hamilton

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510312

  4. Experimental Cancer

    1. Top of page
    2. Masthead
    3. Special Report
    4. Human Cancer
    5. Experimental Cancer
    6. Announcements
    1. Hydrolyzable tannins: Potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo (pages 425–432)

      Hala U. Gali, Elisabeth M. Perchellet, Darren S. Klish, Jan M. Johnson and Jean-Pierre Perchellet

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510315

    2. Pharmacologic interactions between the resistance-modifying cyclosporine sdz psc 833 and etoposide (VP 16–213) enhance In Vivo cytostatic activity and toxicity (pages 433–438)

      Roland P. Keller, Hans J. Altermatt, Peter Donatsch, Hans Zihlmann, Jean A. Laissue and Peter C. Hiestand

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510316

    3. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro (pages 439–444)

      John A. Foekens, Anieta M. Sieuwerts, Elisabeth M. J. Stuurman-Smeets, Lambert C. J. Dorssers, Els M. J. J. Berns and Jan G. M. Klijn

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510317

    4. Increased expression of αIIb β3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability (pages 445–451)

      Y. S. Chang, Y. Q. Chen, J. Timar, K. K. Nelson, I. M. Grossi, L. A. Fitzgerald, C. A. Diglio and K. V. Honn

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510318

    5. A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen (pages 459–465)

      Franz-Josef Gaida, Ursula Fenger, Christoph Wagener and Michael Neumaier

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510320

    6. The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors (pages 470–475)

      O. C. Boerman, R. M. Sharkey, R. D. Blumenthal, R. L. Aninipot and D. M. Goldenberg

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510322

    7. SOD2: A new type of tumor-suppressor gene? (pages 476–480)

      A. Bravard, L. Sabatier, F. Hoffschir, M. Ricoul, C. Luccioni and B. Dutrillaux

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510323

    8. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells (pages 481–488)

      C. D'Onofrio, C. Amici, A. Puglianiello, I. Faraoni, G. Lanzilli, M. G. Santoro and E. Bonmassar

      Version of Record online: 18 JUL 2006 | DOI: 10.1002/ijc.2910510324

    9. High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point (pages 489–498)

      Toshiharu Furukawa, Tetsuro Kubota, Masahiko Watanabe, Tetsuya Takahara, Hiroshi Yamaguchi, Tooru Takeuchi, Suguru Kase, Susumu Kodaira, Kyuya Ishibiki, Masaki Kitajima and Robert M. Hoffman

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510325

    10. Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cells (pages 499–505)

      S. Miotti, S. Alberti, P. Facheris, L. Mantovani, Mara Fornaro, Manuela Stella, S. Ménard, S. Canevari and M. I. Colnaghi

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510326

  5. Announcements

    1. Top of page
    2. Masthead
    3. Special Report
    4. Human Cancer
    5. Experimental Cancer
    6. Announcements
    1. Announcements (page 508)

      Version of Record online: 17 JUL 2006 | DOI: 10.1002/ijc.2910510327

SEARCH

SEARCH BY CITATION